FREQUENCY OF ACUTE KIDNEY INJURY IN CASES OF LIVER CIRRHOSIS: A CROSS-SECTIONAL STUDY

H KHALIL; AS KHAN; W AHMAD; B AHEED; M OWAIS; R CHANDIO

doi:10.54112/bcsrj.v2024i1.1067

Authors

H KHALIL Department of Nephrology, Rehman medical institute Peshawar, Pakistan
AS KHAN Shifa International Hospital Islamabad, Pakistan
W AHMAD Department of Nephrology, Rehman medical institute Peshawar, Pakistan
B AHEED Department of Biochemistry, Jinnah Sindh Medical University, Karachi, Pakistan
M OWAIS Department of Nephrology, Rehman medical institute Peshawar, Pakistan
R CHANDIO Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, GIMS, GAMBAT, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1067

Keywords:

Acute Kidney Injury, Liver Cirrhosis, Viral Hepatitis, Serum Creatinine, Hyponatremia, Mortality, Renal Dysfunction

Abstract

Acute kidney injury (AKI) frequently complicates the clinical course of liver cirrhosis, impacting patient outcomes significantly. Understanding the epidemiology of AKI in this population is crucial for timely intervention and management. Objective: To assess the frequency and clinical outcomes of acute kidney injury in patients with liver cirrhosis. Methods: Following ethical approval, this descriptive cross-sectional study was conducted at the Department of Nephrology from December 2023 to June 2024. A total of 231 patients aged 18 years and older with a confirmed diagnosis of liver cirrhosis were included. The frequency of AKI was determined using standard criteria. Data analysis was performed using SPSS 24, employing Independent samples t-tests to evaluate differences between patients with and without AKI, with a significance level set at P < 0.05.Results: Among the 231 cirrhotic patients (mean age: 52.5±10.61 years; 83.1% male), AKI was identified in 55 patients (23.8%). Patients with AKI exhibited higher mean serum creatinine (2.99±0.44 mg/dL) and blood urea nitrogen (66.64±9.92 mg/dL), along with lower sodium levels (129.37±4.14 mmol/L) and elevated total bilirubin (5.23±1.37 mg/dL) compared to their non-AKI counterparts. The average length of hospital stay was significantly longer for AKI patients (14.35±3.22 days) compared to non-AKI patients (7.37±1.92 days), and mortality was higher in the AKI group (12.7% vs. 1.7%). Conclusion: Our study highlights a significant prevalence of AKI among patients with liver cirrhosis, particularly affecting those with viral hepatitis B and C. The findings emphasize the need for vigilant monitoring and early therapeutic interventions in this vulnerable population to improve outcomes.

Downloads

Download data is not yet available.

References

Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, Hillien SAS, et al. Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study. Clinical and translational gastroenterology. 2021;12(5):e00359.

Huelin P, Solà E, Elia C, Solé C, Risso A, Moreira R, et al. Neutrophil gelatinase‐associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study. Hepatology. 2019;70(1):319-33.

Yoo J-J, Kim SG, Kim YS, Lee B, Lee MH, Jeong SW, et al. Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex. Journal of hepatology. 2019;70(5):847-54.

Wong F, Reddy KR, O’Leary JG, Tandon P, Biggins SW, Garcia‐Tsao G, et al. Impact of chronic kidney disease on outcomes in cirrhosis. Liver Transplantation. 2019;25(6):870-80.

Hampel H, Bynum GD, Zamora E, El-Serag HB. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Official journal of the American College of Gastroenterology| ACG. 2001;96(7):2206-10.

Garcia‐Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008;48(6):2064-77.

Wong F, Reddy KR, Tandon P, Lai JC, Jagarlamudi N, Weir V, et al. The prediction of in‐hospital mortality in decompensated cirrhosis with acute‐on‐chronic liver failure. Liver Transplantation. 2022;28(4):560-70.

Barreto R, Fagundes C, Guevara M, Sola E, Pereira G, Rodríguez E, et al. Type‐1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology. 2014;59(4):1505-13.

Kumar U, Kumar R, Jha SK, Jha AK, Dayal VM, Kumar A. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: a prospective observational study. Indian Journal of Gastroenterology. 2020;39:457-64.

Musunuri B, Gopal S, Tantry BV, Shenoy S, Shetty AJ. Predictors of short-term mortality in patients of cirrhosis of liver presenting as acute kidney injury: an In-hospital prospective observational study. Journal of Clinical and Experimental Hepatology. 2023;13(6):989-96.

Tariq R, Hadi Y, Chahal K, Reddy S, Salameh H, Singal AK. Incidence, mortality and predictors of acute kidney injury in patients with cirrhosis: a systematic review and meta-analysis. Journal of Clinical and Translational Hepatology. 2020;8(2):135.

Ning Y, Zou X, Xu J, Wang X, Ding M, Lu H. Impact of acute kidney injury on the risk of mortality in patients with cirrhosis: a systematic review and meta-analysis. Renal Failure. 2022;44(1):1934-47.

Mohan PB, Nagaraju SP, Musunuri B, Rajpurohit S, Bhat G, Shetty S. Study of prevalence, risk factors for acute kidney injury, and mortality in liver cirrhosis patients. Irish Journal of Medical Science (1971-). 2024:1-9.

Thapa P, Sudhamshu K, Hamal AB, Sharma D, Khadka S, Karki N, et al. Prevalence of acute kidney injury in patients with liver cirrhosis. JNMA: Journal of the Nepal Medical Association. 2020;58(228):554.